Page last updated: 2024-08-23

azimexon and tuftsin

azimexon has been researched along with tuftsin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giroud, JP; Moachon, L; Roch-Arveiller, M; Tissot, M1
Hadden, JW1
Chirigos, MA1
Bruley-Rosset, M; Florentin, I; Kiger, N; Martinez, J; Mathé, G; Schulz, J1
Bruley-Rosset, M; Florentin, I; Goutner, A; Mathé, G; Serrou, B1

Other Studies

5 other study(ies) available for azimexon and tuftsin

ArticleYear
Effect of immunomodulating agents on leucocyte chemotaxis and cyclic nucleotides.
    Agents and actions, 1982, Volume: 12, Issue:3

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Aziridines; Chemotaxis, Leukocyte; Cyclic AMP; Cyclic GMP; Immunity; Inosine Pranobex; Leukocytes; Levamisole; Rats; Tuftsin

1982
Chemically defined immunotherapeutic agents.
    Progress in clinical and biological research, 1983, Volume: 132E

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Aziridines; Benzimidazoles; Cimetidine; Ditiocarb; Humans; Hypoxanthines; Inosine Pranobex; Leucine; Levamisole; Mice; Neoplasms; Pyran Copolymer; Tuftsin

1983
Overview of chemicals and biologicals capable of regulating immunity.
    Progress in clinical and biological research, 1984, Volume: 161

    Topics: Adjuvants, Immunologic; Animal Diseases; Animals; Aziridines; Carboxymethylcellulose Sodium; Cimetidine; Humans; Hypoxanthines; Imidazoles; Immunity; Inosine Pranobex; Levamisole; Poly I-C; Polylysine; Pyran Copolymer; Tuftsin

1984
In vivo immunomodulating properties of two synthetic agents: azimexon and tuftsin.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1980, Volume: 75

    Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Antibody-Dependent Cell Cytotoxicity; Aziridines; Azirines; Female; Hypersensitivity, Delayed; Immunoglobulin Fragments; Lymphocytes; Macrophages; Mice; Mitogens; Spleen; Tuftsin

1980
Three new agents for immunotherapy trials: azimexon, bestatin, and tuftsin.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1982, Volume: 80

    Topics: Adjuvants, Immunologic; Animals; Aziridines; Azirines; Cytotoxicity, Immunologic; Drug Evaluation, Preclinical; Immunoglobulin Fragments; Immunotherapy; Leucine; Mice; Neoplasms, Experimental; T-Lymphocytes; Tuftsin

1982
chemdatabank.com